nodes	percent_of_prediction	percent_of_DWPC	metapath
Gentamicin—LRP2—Vitamin D (calciferol) metabolism—CYP24A1—multiple sclerosis	0.118	0.253	CbGpPWpGaD
Gentamicin—LRP2—Vitamin D (calciferol) metabolism—CYP27B1—multiple sclerosis	0.118	0.253	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of steroid hormones and vitamin D—CYP27B1—multiple sclerosis	0.0341	0.0733	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of steroid hormones and vitamin D—CYP24A1—multiple sclerosis	0.0341	0.0733	CbGpPWpGaD
Gentamicin—LRP2—retina—multiple sclerosis	0.0281	0.193	CbGeAlD
Gentamicin—LRP2—Retinoid metabolism and transport—GPC5—multiple sclerosis	0.0262	0.0563	CbGpPWpGaD
Gentamicin—LRP2—medulla oblongata—multiple sclerosis	0.0203	0.14	CbGeAlD
Gentamicin—LRP2—midbrain—multiple sclerosis	0.0186	0.128	CbGeAlD
Gentamicin—LRP2—spinal cord—multiple sclerosis	0.0181	0.125	CbGeAlD
Gentamicin—LRP2—nervous system—multiple sclerosis	0.0153	0.105	CbGeAlD
Gentamicin—LRP2—central nervous system—multiple sclerosis	0.0147	0.101	CbGeAlD
Gentamicin—LRP2—cerebellum—multiple sclerosis	0.0144	0.0987	CbGeAlD
Gentamicin—LRP2—Diseases associated with visual transduction—GPC5—multiple sclerosis	0.0134	0.0288	CbGpPWpGaD
Gentamicin—LRP2—brain—multiple sclerosis	0.0117	0.0802	CbGeAlD
Gentamicin—LRP2—Vitamin B12 Metabolism—CCL5—multiple sclerosis	0.00769	0.0165	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of steroid hormones and vitamin D—POMC—multiple sclerosis	0.00767	0.0165	CbGpPWpGaD
Gentamicin—LRP2—Retinoid metabolism and transport—APOE—multiple sclerosis	0.00751	0.0161	CbGpPWpGaD
Gentamicin—LRP2—Vitamin B12 Metabolism—APOE—multiple sclerosis	0.00631	0.0135	CbGpPWpGaD
Gentamicin—LRP2—Vitamin B12 Metabolism—ICAM1—multiple sclerosis	0.00592	0.0127	CbGpPWpGaD
Gentamicin—LRP2—Vitamin B12 Metabolism—CCL2—multiple sclerosis	0.0053	0.0114	CbGpPWpGaD
Gentamicin—LRP2—Vitamin B12 Metabolism—ALB—multiple sclerosis	0.00494	0.0106	CbGpPWpGaD
Gentamicin—LRP2—Vitamin B12 Metabolism—IFNG—multiple sclerosis	0.00451	0.00968	CbGpPWpGaD
Gentamicin—SLC22A6—brain—multiple sclerosis	0.0044	0.0303	CbGeAlD
Gentamicin—LRP2—Vitamin B12 Metabolism—IL1B—multiple sclerosis	0.00402	0.00864	CbGpPWpGaD
Gentamicin—LRP2—Diseases associated with visual transduction—APOE—multiple sclerosis	0.00383	0.00824	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.0035	0.00751	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.0035	0.00751	CbGpPWpGaD
Gentamicin—LRP2—Vitamin B12 Metabolism—TNF—multiple sclerosis	0.00292	0.00627	CbGpPWpGaD
Gentamicin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.00246	0.0053	CbGpPWpGaD
Gentamicin—LRP2—Vitamin B12 Metabolism—IL6—multiple sclerosis	0.00235	0.00506	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—SRM—multiple sclerosis	0.00221	0.00475	CbGpPWpGaD
Gentamicin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.00172	0.0037	CbGpPWpGaD
Gentamicin—LRP2—Disease—GPC5—multiple sclerosis	0.0017	0.00365	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—LINGO1—multiple sclerosis	0.00162	0.00347	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—CYP24A1—multiple sclerosis	0.00156	0.00335	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—CYP27B1—multiple sclerosis	0.00156	0.00335	CbGpPWpGaD
Gentamicin—Headache—Fingolimod—multiple sclerosis	0.00155	0.00399	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.00152	0.00327	CbGpPWpGaD
Gentamicin—Extravasation—Methotrexate—multiple sclerosis	0.00148	0.0038	CcSEcCtD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.00148	0.00317	CbGpPWpGaD
Gentamicin—Purpura—Triamcinolone—multiple sclerosis	0.00147	0.00378	CcSEcCtD
Gentamicin—Weight decreased—Mitoxantrone—multiple sclerosis	0.00147	0.00378	CcSEcCtD
Gentamicin—Arthralgia—Cladribine—multiple sclerosis	0.00147	0.00377	CcSEcCtD
Gentamicin—Anaphylactoid reaction—Triamcinolone—multiple sclerosis	0.00147	0.00377	CcSEcCtD
Gentamicin—Anaphylactoid reaction—Methylprednisolone—multiple sclerosis	0.00146	0.00376	CcSEcCtD
Gentamicin—LRP2—Metabolism—GPC5—multiple sclerosis	0.00142	0.00306	CbGpPWpGaD
Gentamicin—Alopecia—Azathioprine—multiple sclerosis	0.00142	0.00365	CcSEcCtD
Gentamicin—Confusional state—Cladribine—multiple sclerosis	0.00142	0.00364	CcSEcCtD
Gentamicin—Stomatitis—Mitoxantrone—multiple sclerosis	0.00141	0.00363	CcSEcCtD
Gentamicin—Oliguria—Methotrexate—multiple sclerosis	0.0014	0.0036	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—TAGAP—multiple sclerosis	0.0014	0.00301	CbGpPWpGaD
Gentamicin—Thrombocytopenia—Cladribine—multiple sclerosis	0.00138	0.00354	CcSEcCtD
Gentamicin—Muscular weakness—Prednisolone—multiple sclerosis	0.00136	0.0035	CcSEcCtD
Gentamicin—Visual disturbance—Betamethasone—multiple sclerosis	0.00136	0.00349	CcSEcCtD
Gentamicin—Visual disturbance—Dexamethasone—multiple sclerosis	0.00136	0.00349	CcSEcCtD
Gentamicin—Agranulocytosis—Mitoxantrone—multiple sclerosis	0.00135	0.00348	CcSEcCtD
Gentamicin—Anaphylactoid reaction—Dexamethasone—multiple sclerosis	0.00133	0.00342	CcSEcCtD
Gentamicin—Anaphylactoid reaction—Betamethasone—multiple sclerosis	0.00133	0.00342	CcSEcCtD
Gentamicin—Hypotension—Cladribine—multiple sclerosis	0.00131	0.00338	CcSEcCtD
Gentamicin—Lethargy—Dexamethasone—multiple sclerosis	0.00131	0.00338	CcSEcCtD
Gentamicin—Lethargy—Betamethasone—multiple sclerosis	0.00131	0.00338	CcSEcCtD
Gentamicin—Anaemia—Azathioprine—multiple sclerosis	0.00129	0.00333	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Cladribine—multiple sclerosis	0.00128	0.00329	CcSEcCtD
Gentamicin—Paraesthesia—Cladribine—multiple sclerosis	0.00126	0.00324	CcSEcCtD
Gentamicin—Leukopenia—Azathioprine—multiple sclerosis	0.00125	0.00322	CcSEcCtD
Gentamicin—Vascular purpura—Prednisone—multiple sclerosis	0.00125	0.00322	CcSEcCtD
Gentamicin—Muscular weakness—Triamcinolone—multiple sclerosis	0.00125	0.00322	CcSEcCtD
Gentamicin—Muscular weakness—Methylprednisolone—multiple sclerosis	0.00125	0.00321	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—S1PR1—multiple sclerosis	0.00122	0.00263	CbGpPWpGaD
Gentamicin—Decreased appetite—Cladribine—multiple sclerosis	0.00122	0.00314	CcSEcCtD
Gentamicin—Arthralgia—Azathioprine—multiple sclerosis	0.00119	0.00307	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—GPC5—multiple sclerosis	0.00119	0.00256	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—RRM1—multiple sclerosis	0.00118	0.00254	CbGpPWpGaD
Gentamicin—Hypokalaemia—Betamethasone—multiple sclerosis	0.00117	0.00301	CcSEcCtD
Gentamicin—Hypokalaemia—Dexamethasone—multiple sclerosis	0.00117	0.00301	CcSEcCtD
Gentamicin—Neuropathy peripheral—Prednisolone—multiple sclerosis	0.00117	0.003	CcSEcCtD
Gentamicin—Purpura—Prednisone—multiple sclerosis	0.00116	0.00299	CcSEcCtD
Gentamicin—Feeling abnormal—Cladribine—multiple sclerosis	0.00116	0.00298	CcSEcCtD
Gentamicin—Alopecia—Mitoxantrone—multiple sclerosis	0.00115	0.00295	CcSEcCtD
Gentamicin—Lethargy—Prednisone—multiple sclerosis	0.00114	0.00294	CcSEcCtD
Gentamicin—Muscular weakness—Dexamethasone—multiple sclerosis	0.00114	0.00292	CcSEcCtD
Gentamicin—Muscular weakness—Betamethasone—multiple sclerosis	0.00114	0.00292	CcSEcCtD
Gentamicin—Erythema—Mitoxantrone—multiple sclerosis	0.00113	0.00291	CcSEcCtD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.00112	0.00241	CbGpPWpGaD
Gentamicin—Thrombocytopenia—Azathioprine—multiple sclerosis	0.00112	0.00288	CcSEcCtD
Gentamicin—Urticaria—Cladribine—multiple sclerosis	0.00112	0.00287	CcSEcCtD
Gentamicin—Body temperature increased—Cladribine—multiple sclerosis	0.00111	0.00286	CcSEcCtD
Gentamicin—LRP2—Disease—RPL5—multiple sclerosis	0.00111	0.00238	CbGpPWpGaD
Gentamicin—Neuropathy peripheral—Triamcinolone—multiple sclerosis	0.00107	0.00275	CcSEcCtD
Gentamicin—Neuropathy peripheral—Methylprednisolone—multiple sclerosis	0.00107	0.00275	CcSEcCtD
Gentamicin—Hypotension—Azathioprine—multiple sclerosis	0.00107	0.00275	CcSEcCtD
Gentamicin—LRP2—Disease—SLC11A1—multiple sclerosis	0.00106	0.00228	CbGpPWpGaD
Gentamicin—Anaemia—Mitoxantrone—multiple sclerosis	0.00105	0.00269	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.00104	0.00268	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—RGS1—multiple sclerosis	0.00104	0.00224	CbGpPWpGaD
Gentamicin—Hypersensitivity—Cladribine—multiple sclerosis	0.00104	0.00266	CcSEcCtD
Gentamicin—Visual impairment—Prednisolone—multiple sclerosis	0.00103	0.00264	CcSEcCtD
Gentamicin—Hypokalaemia—Prednisone—multiple sclerosis	0.00102	0.00262	CcSEcCtD
Gentamicin—Leukopenia—Mitoxantrone—multiple sclerosis	0.00101	0.00261	CcSEcCtD
Gentamicin—Weight decreased—Betamethasone—multiple sclerosis	0.00101	0.00259	CcSEcCtD
Gentamicin—Weight decreased—Dexamethasone—multiple sclerosis	0.00101	0.00259	CcSEcCtD
Gentamicin—Pruritus—Cladribine—multiple sclerosis	0.000995	0.00256	CcSEcCtD
Gentamicin—Muscular weakness—Prednisone—multiple sclerosis	0.000989	0.00254	CcSEcCtD
Gentamicin—Visual disturbance—Methotrexate—multiple sclerosis	0.000989	0.00254	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—GPR65—multiple sclerosis	0.000987	0.00212	CbGpPWpGaD
Gentamicin—Convulsion—Mitoxantrone—multiple sclerosis	0.000981	0.00252	CcSEcCtD
Gentamicin—Hypertension—Mitoxantrone—multiple sclerosis	0.000978	0.00251	CcSEcCtD
Gentamicin—Hallucination—Methylprednisolone—multiple sclerosis	0.000974	0.0025	CcSEcCtD
Gentamicin—Neuropathy peripheral—Betamethasone—multiple sclerosis	0.000972	0.0025	CcSEcCtD
Gentamicin—Neuropathy peripheral—Dexamethasone—multiple sclerosis	0.000972	0.0025	CcSEcCtD
Gentamicin—Anaphylactoid reaction—Methotrexate—multiple sclerosis	0.000968	0.00249	CcSEcCtD
Gentamicin—Arthralgia—Mitoxantrone—multiple sclerosis	0.000964	0.00248	CcSEcCtD
Gentamicin—Lethargy—Methotrexate—multiple sclerosis	0.000956	0.00246	CcSEcCtD
Gentamicin—Visual impairment—Methylprednisolone—multiple sclerosis	0.000944	0.00243	CcSEcCtD
Gentamicin—Feeling abnormal—Azathioprine—multiple sclerosis	0.000942	0.00242	CcSEcCtD
Gentamicin—Confusional state—Mitoxantrone—multiple sclerosis	0.000932	0.0024	CcSEcCtD
Gentamicin—Dizziness—Cladribine—multiple sclerosis	0.00093	0.00239	CcSEcCtD
Gentamicin—Erythema—Prednisolone—multiple sclerosis	0.000929	0.00239	CcSEcCtD
Gentamicin—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.000924	0.00238	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.000916	0.00197	CbGpPWpGaD
Gentamicin—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000905	0.00233	CcSEcCtD
Gentamicin—Body temperature increased—Azathioprine—multiple sclerosis	0.000904	0.00232	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—CCR1—multiple sclerosis	0.000902	0.00194	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CXCL13—multiple sclerosis	0.000902	0.00194	CbGpPWpGaD
Gentamicin—Vomiting—Cladribine—multiple sclerosis	0.000894	0.0023	CcSEcCtD
Gentamicin—Rash—Cladribine—multiple sclerosis	0.000887	0.00228	CcSEcCtD
Gentamicin—Hallucination—Betamethasone—multiple sclerosis	0.000886	0.00228	CcSEcCtD
Gentamicin—Hallucination—Dexamethasone—multiple sclerosis	0.000886	0.00228	CcSEcCtD
Gentamicin—Dermatitis—Cladribine—multiple sclerosis	0.000886	0.00228	CcSEcCtD
Gentamicin—Headache—Cladribine—multiple sclerosis	0.000881	0.00226	CcSEcCtD
Gentamicin—Weight decreased—Prednisone—multiple sclerosis	0.000877	0.00225	CcSEcCtD
Gentamicin—Hypotension—Mitoxantrone—multiple sclerosis	0.000864	0.00222	CcSEcCtD
Gentamicin—Visual impairment—Betamethasone—multiple sclerosis	0.000858	0.00221	CcSEcCtD
Gentamicin—Visual impairment—Dexamethasone—multiple sclerosis	0.000858	0.00221	CcSEcCtD
Gentamicin—Erythema—Triamcinolone—multiple sclerosis	0.000854	0.0022	CcSEcCtD
Gentamicin—Erythema—Methylprednisolone—multiple sclerosis	0.000852	0.00219	CcSEcCtD
Gentamicin—Neuropathy peripheral—Prednisone—multiple sclerosis	0.000847	0.00218	CcSEcCtD
Gentamicin—LRP2—Disease—CD28—multiple sclerosis	0.000846	0.00182	CbGpPWpGaD
Gentamicin—Hypersensitivity—Azathioprine—multiple sclerosis	0.000842	0.00216	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000842	0.00216	CcSEcCtD
Gentamicin—Nausea—Cladribine—multiple sclerosis	0.000835	0.00215	CcSEcCtD
Gentamicin—Vertigo—Prednisolone—multiple sclerosis	0.000835	0.00215	CcSEcCtD
Gentamicin—Paraesthesia—Mitoxantrone—multiple sclerosis	0.00083	0.00213	CcSEcCtD
Gentamicin—Convulsion—Prednisolone—multiple sclerosis	0.000805	0.00207	CcSEcCtD
Gentamicin—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000803	0.00206	CcSEcCtD
Gentamicin—Hypertension—Prednisolone—multiple sclerosis	0.000802	0.00206	CcSEcCtD
Gentamicin—Eosinophilia—Methotrexate—multiple sclerosis	0.000802	0.00206	CcSEcCtD
Gentamicin—Alopecia—Betamethasone—multiple sclerosis	0.000787	0.00202	CcSEcCtD
Gentamicin—Alopecia—Dexamethasone—multiple sclerosis	0.000787	0.00202	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.000787	0.00169	CbGpPWpGaD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000783	0.00168	CbGpPWpGaD
Gentamicin—Erythema—Dexamethasone—multiple sclerosis	0.000775	0.00199	CcSEcCtD
Gentamicin—Erythema—Betamethasone—multiple sclerosis	0.000775	0.00199	CcSEcCtD
Gentamicin—Hallucination—Prednisone—multiple sclerosis	0.000772	0.00198	CcSEcCtD
Gentamicin—Vertigo—Triamcinolone—multiple sclerosis	0.000768	0.00197	CcSEcCtD
Gentamicin—Vertigo—Methylprednisolone—multiple sclerosis	0.000766	0.00197	CcSEcCtD
Gentamicin—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000762	0.00196	CcSEcCtD
Gentamicin—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000758	0.00195	CcSEcCtD
Gentamicin—Dizziness—Azathioprine—multiple sclerosis	0.000756	0.00194	CcSEcCtD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000751	0.00161	CbGpPWpGaD
Gentamicin—Convulsion—Triamcinolone—multiple sclerosis	0.00074	0.0019	CcSEcCtD
Gentamicin—Convulsion—Methylprednisolone—multiple sclerosis	0.000739	0.0019	CcSEcCtD
Gentamicin—Hypertension—Triamcinolone—multiple sclerosis	0.000738	0.0019	CcSEcCtD
Gentamicin—Hypertension—Methylprednisolone—multiple sclerosis	0.000736	0.00189	CcSEcCtD
Gentamicin—Urticaria—Mitoxantrone—multiple sclerosis	0.000734	0.00189	CcSEcCtD
Gentamicin—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000731	0.00188	CcSEcCtD
Gentamicin—Vomiting—Azathioprine—multiple sclerosis	0.000727	0.00187	CcSEcCtD
Gentamicin—Arthralgia—Methylprednisolone—multiple sclerosis	0.000726	0.00187	CcSEcCtD
Gentamicin—Rash—Azathioprine—multiple sclerosis	0.000721	0.00185	CcSEcCtD
Gentamicin—Dermatitis—Azathioprine—multiple sclerosis	0.00072	0.00185	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.000717	0.00154	CbGpPWpGaD
Gentamicin—Headache—Azathioprine—multiple sclerosis	0.000716	0.00184	CcSEcCtD
Gentamicin—Stomatitis—Methotrexate—multiple sclerosis	0.000704	0.00181	CcSEcCtD
Gentamicin—Confusional state—Methylprednisolone—multiple sclerosis	0.000702	0.0018	CcSEcCtD
Gentamicin—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000697	0.00179	CcSEcCtD
Gentamicin—Vertigo—Betamethasone—multiple sclerosis	0.000696	0.00179	CcSEcCtD
Gentamicin—Vertigo—Dexamethasone—multiple sclerosis	0.000696	0.00179	CcSEcCtD
Gentamicin—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000696	0.00179	CcSEcCtD
Gentamicin—Alopecia—Prednisone—multiple sclerosis	0.000685	0.00176	CcSEcCtD
Gentamicin—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000681	0.00175	CcSEcCtD
Gentamicin—Paraesthesia—Prednisolone—multiple sclerosis	0.000681	0.00175	CcSEcCtD
Gentamicin—Nausea—Azathioprine—multiple sclerosis	0.000679	0.00175	CcSEcCtD
Gentamicin—LRP2—Metabolism—BCHE—multiple sclerosis	0.000678	0.00146	CbGpPWpGaD
Gentamicin—Erythema—Prednisone—multiple sclerosis	0.000675	0.00174	CcSEcCtD
Gentamicin—Agranulocytosis—Methotrexate—multiple sclerosis	0.000674	0.00173	CcSEcCtD
Gentamicin—Convulsion—Betamethasone—multiple sclerosis	0.000672	0.00173	CcSEcCtD
Gentamicin—Convulsion—Dexamethasone—multiple sclerosis	0.000672	0.00173	CcSEcCtD
Gentamicin—Hypertension—Dexamethasone—multiple sclerosis	0.000669	0.00172	CcSEcCtD
Gentamicin—Hypertension—Betamethasone—multiple sclerosis	0.000669	0.00172	CcSEcCtD
Gentamicin—Hypotension—Methylprednisolone—multiple sclerosis	0.00065	0.00167	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—CCL3—multiple sclerosis	0.000643	0.00138	CbGpPWpGaD
Gentamicin—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000635	0.00163	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000634	0.00163	CcSEcCtD
Gentamicin—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000633	0.00163	CcSEcCtD
Gentamicin—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000633	0.00163	CcSEcCtD
Gentamicin—Paraesthesia—Triamcinolone—multiple sclerosis	0.000626	0.00161	CcSEcCtD
Gentamicin—Feeling abnormal—Prednisolone—multiple sclerosis	0.000625	0.00161	CcSEcCtD
Gentamicin—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000625	0.00161	CcSEcCtD
Gentamicin—Visual impairment—Methotrexate—multiple sclerosis	0.000625	0.00161	CcSEcCtD
Gentamicin—Anaemia—Prednisone—multiple sclerosis	0.000624	0.0016	CcSEcCtD
Gentamicin—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000619	0.00159	CcSEcCtD
Gentamicin—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000619	0.00159	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—PTGER4—multiple sclerosis	0.000619	0.00133	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PGR—multiple sclerosis	0.00061	0.00131	CbGpPWpGaD
Gentamicin—Vertigo—Prednisone—multiple sclerosis	0.000607	0.00156	CcSEcCtD
Gentamicin—Tinnitus—Methotrexate—multiple sclerosis	0.000604	0.00155	CcSEcCtD
Gentamicin—LRP2—Disease—CD86—multiple sclerosis	0.000603	0.0013	CbGpPWpGaD
Gentamicin—Urticaria—Prednisolone—multiple sclerosis	0.000602	0.00155	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—CXCR3—multiple sclerosis	0.000598	0.00128	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CD28—multiple sclerosis	0.000592	0.00127	CbGpPWpGaD
Gentamicin—Hypotension—Betamethasone—multiple sclerosis	0.000591	0.00152	CcSEcCtD
Gentamicin—Hypotension—Dexamethasone—multiple sclerosis	0.000591	0.00152	CcSEcCtD
Gentamicin—Vomiting—Mitoxantrone—multiple sclerosis	0.000588	0.00151	CcSEcCtD
Gentamicin—Convulsion—Prednisone—multiple sclerosis	0.000585	0.0015	CcSEcCtD
Gentamicin—Hypertension—Prednisone—multiple sclerosis	0.000583	0.0015	CcSEcCtD
Gentamicin—Rash—Mitoxantrone—multiple sclerosis	0.000583	0.0015	CcSEcCtD
Gentamicin—Dermatitis—Mitoxantrone—multiple sclerosis	0.000582	0.0015	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—CCR2—multiple sclerosis	0.000582	0.00125	CbGpPWpGaD
Gentamicin—Headache—Mitoxantrone—multiple sclerosis	0.000579	0.00149	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000576	0.00148	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000576	0.00148	CcSEcCtD
Gentamicin—Arthralgia—Prednisone—multiple sclerosis	0.000575	0.00148	CcSEcCtD
Gentamicin—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000575	0.00148	CcSEcCtD
Gentamicin—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000573	0.00147	CcSEcCtD
Gentamicin—Alopecia—Methotrexate—multiple sclerosis	0.000573	0.00147	CcSEcCtD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000569	0.00122	CbGpPWpGaD
Gentamicin—Paraesthesia—Betamethasone—multiple sclerosis	0.000568	0.00146	CcSEcCtD
Gentamicin—Paraesthesia—Dexamethasone—multiple sclerosis	0.000568	0.00146	CcSEcCtD
Gentamicin—Erythema—Methotrexate—multiple sclerosis	0.000564	0.00145	CcSEcCtD
Gentamicin—Hypersensitivity—Prednisolone—multiple sclerosis	0.000559	0.00144	CcSEcCtD
Gentamicin—Urticaria—Triamcinolone—multiple sclerosis	0.000554	0.00142	CcSEcCtD
Gentamicin—Urticaria—Methylprednisolone—multiple sclerosis	0.000553	0.00142	CcSEcCtD
Gentamicin—Body temperature increased—Triamcinolone—multiple sclerosis	0.000551	0.00142	CcSEcCtD
Gentamicin—Anaphylactic shock—Prednisone—multiple sclerosis	0.000551	0.00142	CcSEcCtD
Gentamicin—Decreased appetite—Betamethasone—multiple sclerosis	0.00055	0.00141	CcSEcCtD
Gentamicin—Decreased appetite—Dexamethasone—multiple sclerosis	0.00055	0.00141	CcSEcCtD
Gentamicin—Nausea—Mitoxantrone—multiple sclerosis	0.000549	0.00141	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—CNR1—multiple sclerosis	0.000537	0.00115	CbGpPWpGaD
Gentamicin—LRP2—Disease—CCR5—multiple sclerosis	0.000535	0.00115	CbGpPWpGaD
Gentamicin—LRP2—Disease—HLA-A—multiple sclerosis	0.000522	0.00112	CbGpPWpGaD
Gentamicin—Anaemia—Methotrexate—multiple sclerosis	0.000521	0.00134	CcSEcCtD
Gentamicin—Feeling abnormal—Betamethasone—multiple sclerosis	0.000521	0.00134	CcSEcCtD
Gentamicin—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000521	0.00134	CcSEcCtD
Gentamicin—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000514	0.00132	CcSEcCtD
Gentamicin—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000513	0.00132	CcSEcCtD
Gentamicin—Vertigo—Methotrexate—multiple sclerosis	0.000507	0.0013	CcSEcCtD
Gentamicin—Leukopenia—Methotrexate—multiple sclerosis	0.000505	0.0013	CcSEcCtD
Gentamicin—Urticaria—Betamethasone—multiple sclerosis	0.000503	0.00129	CcSEcCtD
Gentamicin—Urticaria—Dexamethasone—multiple sclerosis	0.000503	0.00129	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000502	0.00129	CcSEcCtD
Gentamicin—Dizziness—Prednisolone—multiple sclerosis	0.000501	0.00129	CcSEcCtD
Gentamicin—Body temperature increased—Betamethasone—multiple sclerosis	0.0005	0.00129	CcSEcCtD
Gentamicin—Body temperature increased—Dexamethasone—multiple sclerosis	0.0005	0.00129	CcSEcCtD
Gentamicin—Paraesthesia—Prednisone—multiple sclerosis	0.000495	0.00127	CcSEcCtD
Gentamicin—Pruritus—Triamcinolone—multiple sclerosis	0.000493	0.00127	CcSEcCtD
Gentamicin—Pruritus—Methylprednisolone—multiple sclerosis	0.000492	0.00127	CcSEcCtD
Gentamicin—Convulsion—Methotrexate—multiple sclerosis	0.000489	0.00126	CcSEcCtD
Gentamicin—LRP2—Disease—APOE—multiple sclerosis	0.000487	0.00105	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CXCL10—multiple sclerosis	0.000483	0.00104	CbGpPWpGaD
Gentamicin—Arthralgia—Methotrexate—multiple sclerosis	0.00048	0.00123	CcSEcCtD
Gentamicin—Decreased appetite—Prednisone—multiple sclerosis	0.000479	0.00123	CcSEcCtD
Gentamicin—Rash—Prednisolone—multiple sclerosis	0.000478	0.00123	CcSEcCtD
Gentamicin—Dermatitis—Prednisolone—multiple sclerosis	0.000478	0.00123	CcSEcCtD
Gentamicin—Headache—Prednisolone—multiple sclerosis	0.000475	0.00122	CcSEcCtD
Gentamicin—Confusional state—Methotrexate—multiple sclerosis	0.000464	0.00119	CcSEcCtD
Gentamicin—Dizziness—Triamcinolone—multiple sclerosis	0.000461	0.00119	CcSEcCtD
Gentamicin—Anaphylactic shock—Methotrexate—multiple sclerosis	0.00046	0.00118	CcSEcCtD
Gentamicin—Dizziness—Methylprednisolone—multiple sclerosis	0.00046	0.00118	CcSEcCtD
Gentamicin—Feeling abnormal—Prednisone—multiple sclerosis	0.000454	0.00117	CcSEcCtD
Gentamicin—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000451	0.00116	CcSEcCtD
Gentamicin—Nausea—Prednisolone—multiple sclerosis	0.00045	0.00116	CcSEcCtD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.00045	0.000967	CbGpPWpGaD
Gentamicin—Pruritus—Betamethasone—multiple sclerosis	0.000448	0.00115	CcSEcCtD
Gentamicin—Pruritus—Dexamethasone—multiple sclerosis	0.000448	0.00115	CcSEcCtD
Gentamicin—Vomiting—Triamcinolone—multiple sclerosis	0.000443	0.00114	CcSEcCtD
Gentamicin—Vomiting—Methylprednisolone—multiple sclerosis	0.000442	0.00114	CcSEcCtD
Gentamicin—LRP2—Disease—CD80—multiple sclerosis	0.00044	0.000946	CbGpPWpGaD
Gentamicin—Rash—Triamcinolone—multiple sclerosis	0.00044	0.00113	CcSEcCtD
Gentamicin—Dermatitis—Triamcinolone—multiple sclerosis	0.000439	0.00113	CcSEcCtD
Gentamicin—Rash—Methylprednisolone—multiple sclerosis	0.000439	0.00113	CcSEcCtD
Gentamicin—Dermatitis—Methylprednisolone—multiple sclerosis	0.000438	0.00113	CcSEcCtD
Gentamicin—Urticaria—Prednisone—multiple sclerosis	0.000438	0.00112	CcSEcCtD
Gentamicin—Headache—Triamcinolone—multiple sclerosis	0.000437	0.00112	CcSEcCtD
Gentamicin—Headache—Methylprednisolone—multiple sclerosis	0.000436	0.00112	CcSEcCtD
Gentamicin—Body temperature increased—Prednisone—multiple sclerosis	0.000436	0.00112	CcSEcCtD
Gentamicin—Hypotension—Methotrexate—multiple sclerosis	0.00043	0.00111	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—CD86—multiple sclerosis	0.000423	0.000908	CbGpPWpGaD
Gentamicin—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.00042	0.00108	CcSEcCtD
Gentamicin—Dizziness—Dexamethasone—multiple sclerosis	0.000418	0.00108	CcSEcCtD
Gentamicin—Dizziness—Betamethasone—multiple sclerosis	0.000418	0.00108	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—CCL5—multiple sclerosis	0.000416	0.000894	CbGpPWpGaD
Gentamicin—Nausea—Triamcinolone—multiple sclerosis	0.000414	0.00106	CcSEcCtD
Gentamicin—Paraesthesia—Methotrexate—multiple sclerosis	0.000413	0.00106	CcSEcCtD
Gentamicin—Nausea—Methylprednisolone—multiple sclerosis	0.000413	0.00106	CcSEcCtD
Gentamicin—LRP2—Metabolism—APOE—multiple sclerosis	0.000408	0.000876	CbGpPWpGaD
Gentamicin—Hypersensitivity—Prednisone—multiple sclerosis	0.000406	0.00104	CcSEcCtD
Gentamicin—Vomiting—Dexamethasone—multiple sclerosis	0.000402	0.00103	CcSEcCtD
Gentamicin—Vomiting—Betamethasone—multiple sclerosis	0.000402	0.00103	CcSEcCtD
Gentamicin—Decreased appetite—Methotrexate—multiple sclerosis	0.0004	0.00103	CcSEcCtD
Gentamicin—Rash—Betamethasone—multiple sclerosis	0.000399	0.00103	CcSEcCtD
Gentamicin—Rash—Dexamethasone—multiple sclerosis	0.000399	0.00103	CcSEcCtD
Gentamicin—Dermatitis—Betamethasone—multiple sclerosis	0.000399	0.00102	CcSEcCtD
Gentamicin—Dermatitis—Dexamethasone—multiple sclerosis	0.000399	0.00102	CcSEcCtD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000398	0.000854	CbGpPWpGaD
Gentamicin—Headache—Betamethasone—multiple sclerosis	0.000396	0.00102	CcSEcCtD
Gentamicin—Headache—Dexamethasone—multiple sclerosis	0.000396	0.00102	CcSEcCtD
Gentamicin—Pruritus—Prednisone—multiple sclerosis	0.00039	0.001	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—SPP1—multiple sclerosis	0.000385	0.000828	CbGpPWpGaD
Gentamicin—Feeling abnormal—Methotrexate—multiple sclerosis	0.000379	0.000975	CcSEcCtD
Gentamicin—Nausea—Betamethasone—multiple sclerosis	0.000376	0.000966	CcSEcCtD
Gentamicin—Nausea—Dexamethasone—multiple sclerosis	0.000376	0.000966	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—CCR5—multiple sclerosis	0.000375	0.000805	CbGpPWpGaD
Gentamicin—LRP2—Disease—TYK2—multiple sclerosis	0.000372	0.000798	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—IL2RA—multiple sclerosis	0.000369	0.000794	CbGpPWpGaD
Gentamicin—Urticaria—Methotrexate—multiple sclerosis	0.000366	0.00094	CcSEcCtD
Gentamicin—Dizziness—Prednisone—multiple sclerosis	0.000364	0.000936	CcSEcCtD
Gentamicin—Body temperature increased—Methotrexate—multiple sclerosis	0.000364	0.000936	CcSEcCtD
Gentamicin—Vomiting—Prednisone—multiple sclerosis	0.00035	0.0009	CcSEcCtD
Gentamicin—LRP2—Metabolism—POMC—multiple sclerosis	0.00035	0.000753	CbGpPWpGaD
Gentamicin—Rash—Prednisone—multiple sclerosis	0.000347	0.000893	CcSEcCtD
Gentamicin—Dermatitis—Prednisone—multiple sclerosis	0.000347	0.000892	CcSEcCtD
Gentamicin—Headache—Prednisone—multiple sclerosis	0.000345	0.000887	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—APOE—multiple sclerosis	0.000341	0.000733	CbGpPWpGaD
Gentamicin—Hypersensitivity—Methotrexate—multiple sclerosis	0.000339	0.000872	CcSEcCtD
Gentamicin—LRP2—Disease—CD4—multiple sclerosis	0.000336	0.000722	CbGpPWpGaD
Gentamicin—Nausea—Prednisone—multiple sclerosis	0.000327	0.000841	CcSEcCtD
Gentamicin—Pruritus—Methotrexate—multiple sclerosis	0.000326	0.000837	CcSEcCtD
Gentamicin—LRP2—Metabolism—ALB—multiple sclerosis	0.000319	0.000686	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CD80—multiple sclerosis	0.000308	0.000662	CbGpPWpGaD
Gentamicin—Dizziness—Methotrexate—multiple sclerosis	0.000305	0.000783	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—POMC—multiple sclerosis	0.000293	0.000629	CbGpPWpGaD
Gentamicin—Vomiting—Methotrexate—multiple sclerosis	0.000293	0.000752	CcSEcCtD
Gentamicin—Rash—Methotrexate—multiple sclerosis	0.00029	0.000746	CcSEcCtD
Gentamicin—Dermatitis—Methotrexate—multiple sclerosis	0.00029	0.000746	CcSEcCtD
Gentamicin—Headache—Methotrexate—multiple sclerosis	0.000288	0.000741	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—CCL2—multiple sclerosis	0.000287	0.000616	CbGpPWpGaD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000282	0.000605	CbGpPWpGaD
Gentamicin—Nausea—Methotrexate—multiple sclerosis	0.000274	0.000703	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—TYK2—multiple sclerosis	0.00026	0.000559	CbGpPWpGaD
Gentamicin—LRP2—Disease—STAT3—multiple sclerosis	0.00026	0.000559	CbGpPWpGaD
Gentamicin—LRP2—Disease—MYC—multiple sclerosis	0.000242	0.000519	CbGpPWpGaD
Gentamicin—LRP2—Disease—TGFB1—multiple sclerosis	0.000241	0.000518	CbGpPWpGaD
Gentamicin—LRP2—Disease—MAPK1—multiple sclerosis	0.000237	0.000508	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—IL2—multiple sclerosis	0.000217	0.000465	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MMP9—multiple sclerosis	0.000205	0.00044	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—STAT3—multiple sclerosis	0.000182	0.000391	CbGpPWpGaD
Gentamicin—LRP2—Disease—IL6—multiple sclerosis	0.000182	0.000391	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MYC—multiple sclerosis	0.000169	0.000364	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—TGFB1—multiple sclerosis	0.000169	0.000363	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MAPK1—multiple sclerosis	0.000166	0.000356	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000143	0.000308	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—IL6—multiple sclerosis	0.000127	0.000273	CbGpPWpGaD
